Joe Biden will address racial and ethnic disparities in infection rates and outcomes

The argument

Joe Biden has already launched a racial equity plan to address the disparities in the COVID-19 response. The COVID-19 Health Disparities Action Act would require the administration to develop an action plan to address the disproportionate impact of COVID-19 among racial and ethnic minority, rural, and other vulnerable populations. Biden's administration would require states to revise testing and contact tracing plans to address these disparities and authorise the development of targeted public awareness campaigns about COVID-19 symptoms, testing, and treatment directed at the marginalised populations. Joe Biden would also ensure that federally funded contact-tracing efforts are tailored to the racial and ethnic diversity of local communities.

Premises

Counter-arguments

Every item of evidence here is a proposal. A launched equity plan, a bill that 'would require' an action plan, an administration that 'would require' states to revise their programmes — these describe intentions rather than outcomes, and the question asks which candidate will be better in practice. Critics argue that comparing one side's announced plan against the other's record is not a comparison at all: plans are written to be attractive and cost nothing to promise, and a named piece of legislation is a proposal until it passes. The mechanisms named are also thin relative to the problem they address. Disparities in infection and outcome trace substantially to who cannot work from home, household density, reliance on public transport, rates of underlying illness, and access to insurance and primary care. Revised testing plans, tailored contact tracers and targeted awareness campaigns operate downstream of all of that. Awareness campaigns in particular assume the gap is one of information, which the evidence on occupational exposure does not support. Opponents add that most of the levers are held by states and cities, not the White House. 'Requiring states to revise' their plans presumes federal authority over public-health administration that is contested and, where it exists, runs through funding conditions that take time to attach and are frequently litigated. Finally, the argument is narrow where the question is broad. Being better for the pandemic turns on vaccine procurement and distribution, testing capacity, economic support, hospital supply and the coherence of public messaging. An argument confined to one dimension, on which the candidate's advantage is a document rather than a result, does not settle the overall comparison the question poses.

Rejecting the premises

[Rejecting P1] A launched plan and a named bill are proposals rather than achievements: the Act 'would require' an action plan only if enacted, so the premise records an intention while the question asks which candidate will in fact be better. [Rejecting P2] Revised testing plans, tailored tracers and awareness campaigns act downstream of the drivers of the disparity — occupational exposure, household density, transit reliance, comorbidity and insurance access — and awareness campaigns in particular presuppose an information gap; most of these levers also sit with states and cities rather than the presidency. [Rejecting C] Even granting the premises, they establish an advantage on one dimension of a question that turns on vaccine procurement, testing capacity, economic support, hospital supply and public messaging, so the conclusion is broader than the evidence offered for it.